Michel D. Wissing
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 8
- Reproductive Medicine top 10%
-
- Prostate Cancer Treatment and Research 12
-
- Cervical Cancer and HPV Research 10
-
- Ubiquitin and proteasome pathways 7
- Histone Deacetylase Inhibitors Research 6
-
- Genital Health and Disease 6
- Bladder and Urothelial Cancer Treatments 5
-
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Sushant K. KachhapHans J. HammersHans GelderblomEduardo L. FrancoMichael A. CarducciMadeleine S.Q. KortenhorstJanet MendoncaWalter H. Gotlieb
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Michel D. Wissing
52 papers receiving 765 citations
Peers
Comparison fields: 5 of 87
- Obstetrics and Gynecology 80
- Reproductive Medicine 81
- Oncology 221
- Pulmonary and Respiratory Medicine 202
- Cancer Research 85
Countries citing papers authored by Michel D. Wissing
This map shows the geographic impact of Michel D. Wissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel D. Wissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel D. Wissing more than expected).
Fields of papers citing papers by Michel D. Wissing
This network shows the impact of papers produced by Michel D. Wissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel D. Wissing. The network helps show where Michel D. Wissing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michel D. Wissing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 19 | |
| 8 | 2020 | 19 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 13 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 2 | |
| 14 | 2015 | 52 | |
| 15 | 2014 | 16 | |
| 16 | 2014 | 38 | |
| 17 | 2013 | 30 | |
| 18 | 2013 | 26 | |
| 19 | 2012 | 89 | |
| 20 | 2010 | 134 |
About Michel D. Wissing
Michel D. Wissing is a scholar working on Obstetrics and Gynecology, Pulmonary and Respiratory Medicine and Oncology, having authored 52 papers that have together received 774 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Cervical Cancer and HPV Research (10 papers), Endometrial and Cervical Cancer Treatments (8 papers), Ubiquitin and proteasome pathways (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Genital Health and Disease (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Obstetrics and Gynecology (80 citations), Reproductive Medicine (81 citations) and Oncology (221 citations). Michel D. Wissing has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Sushant K. Kachhap, Hans J. Hammers, Hans Gelderblom, Eduardo L. Franco, Michael A. Carducci, Madeleine S.Q. Kortenhorst, Janet Mendonca, Walter H. Gotlieb, Zoë R. Greenwald and Luigi Marchionni. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.